- Home
- NEWP vs QTRX Comparison
NEWP vs QTRX Comparison
Compare NEWP & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWP
- QTRX
- Stock Information
- Founded
- NEWP 1972
- QTRX 2007
- Country
- NEWP Canada
- QTRX United States
- Employees
- NEWP N/A
- QTRX N/A
- Industry
- NEWP
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- NEWP
- QTRX Industrials
- Exchange
- NEWP Nasdaq
- QTRX Nasdaq
- Market Cap
- NEWP 199.1M
- QTRX 233.5M
- IPO Year
- NEWP N/A
- QTRX 2017
- Fundamental
- Price
- NEWP $1.44
- QTRX $5.26
- Analyst Decision
- NEWP Strong Buy
- QTRX Buy
- Analyst Count
- NEWP 1
- QTRX 5
- Target Price
- NEWP $5.00
- QTRX $15.60
- AVG Volume (30 Days)
- NEWP 262.4K
- QTRX 676.0K
- Earning Date
- NEWP 05-07-2025
- QTRX 05-12-2025
- Dividend Yield
- NEWP N/A
- QTRX N/A
- EPS Growth
- NEWP N/A
- QTRX N/A
- EPS
- NEWP N/A
- QTRX N/A
- Revenue
- NEWP N/A
- QTRX $135,688,000.00
- Revenue This Year
- NEWP N/A
- QTRX N/A
- Revenue Next Year
- NEWP N/A
- QTRX $14.75
- P/E Ratio
- NEWP N/A
- QTRX N/A
- Revenue Growth
- NEWP N/A
- QTRX 7.71
- 52 Week Low
- NEWP $0.93
- QTRX $4.05
- 52 Week High
- NEWP $2.11
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- NEWP 66.49
- QTRX 47.68
- Support Level
- NEWP $1.35
- QTRX $4.96
- Resistance Level
- NEWP $1.46
- QTRX $5.40
- Average True Range (ATR)
- NEWP 0.08
- QTRX 0.44
- MACD
- NEWP 0.02
- QTRX 0.08
- Stochastic Oscillator
- NEWP 96.23
- QTRX 61.71
About NEWP New Pacific Metals Corp.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.